The Sanofi-part­nered start­up find­ing clin­i­cal tri­als for the 90%

Sanofi want­ed help find­ing new tri­al sites, so a cou­ple years ago they start­ed talk­ing with a start­up down the street – who sent them to Chi­na.

The Paris-based start­up, Ina­to, was build­ing a plat­form to ex­pand the pool of pa­tients for clin­i­cal tri­als. On­ly in­stead of ad­ver­tis­ing or match­ing pa­tients with tri­als, as oth­er young com­pa­nies have, Ina­to was try­ing to match phar­ma com­pa­nies with the vast ma­jor­i­ty of hos­pi­tals that rarely, if ever, host a tri­al, even if they have pa­tients bet­ter suit­ed to a par­tic­u­lar study than a mar­quee name hos­pi­tal. Call them a tri­al plat­form for the 99% – or, by Ina­to’s cal­cu­la­tions, the 90% of sites that are gen­er­al­ly ig­nored in clin­i­cal re­search.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER